Your browser doesn't support javascript.
loading
BRCA1, BRCA2 and PALB2 mutations and CHEK2 c.1100delC in different South African ethnic groups diagnosed with premenopausal and/or triple negative breast cancer.
Francies, F Z; Wainstein, T; De Leeneer, K; Cairns, A; Murdoch, M; Nietz, S; Cubasch, H; Poppe, B; Van Maerken, T; Crombez, B; Coene, I; Kerr, R; Slabbert, J P; Vral, A; Krause, A; Baeyens, A; Claes, K B M.
Afiliación
  • Francies FZ; iThemba LABS-National Research Foundation, Somerset West, South Africa. flavia.zita4@gmail.com.
  • Wainstein T; Department of Radiation Sciences, University of the Witwatersrand, Johannesburg, South Africa. flavia.zita4@gmail.com.
  • De Leeneer K; Division of Human Genetics, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa. Tasha.Wainstein@nhls.ac.za.
  • Cairns A; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. Kim.Deleeneer@ugent.be.
  • Murdoch M; Department of Surgery, Charlotte Maxeke Johannesburg Academic Hospital and Donald Gordon Medical Centre, Johannesburg, South Africa. acairns@tiscali.co.za.
  • Nietz S; Department of Surgery, Charlotte Maxeke Johannesburg Academic Hospital and Donald Gordon Medical Centre, Johannesburg, South Africa. marshall.murdoch@gmail.com.
  • Cubasch H; Department of Surgery, Charlotte Maxeke Johannesburg Academic Hospital and Donald Gordon Medical Centre, Johannesburg, South Africa. sarah.nietz@gmx.de.
  • Poppe B; Batho Pele Breast Unit, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa. hcubasch@worldonline.co.za.
  • Van Maerken T; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. Bruce.Poppe@ugent.be.
  • Crombez B; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. Tom.Vanmaerken@ugent.be.
  • Coene I; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. Brecht.Crombez@ugent.be.
  • Kerr R; Center for Medical Genetics, Ghent University Hospital, Ghent, Belgium. Ilse.Coene@ugent.be.
  • Slabbert JP; Division of Human Genetics, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa. Robyn.Kerr@nhls.ac.za.
  • Vral A; iThemba LABS-National Research Foundation, Somerset West, South Africa. jps@tlabs.ac.za.
  • Krause A; Department of Basic Medical Sciences, Ghent University, Ghent, Belgium. Anne.vral@ugent.be.
  • Baeyens A; Division of Human Genetics, School of Pathology, University of the Witwatersrand, Johannesburg, South Africa. Amanda.Krause@nhls.ac.za.
  • Claes KB; Division of Human Genetics, National Health Laboratory Services, Johannesburg, South Africa. Amanda.Krause@nhls.ac.za.
BMC Cancer ; 15: 912, 2015 Nov 17.
Article en En | MEDLINE | ID: mdl-26577449

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Nucleares / Proteína BRCA1 / Proteínas Supresoras de Tumor / Proteína BRCA2 / Neoplasias de la Mama Triple Negativas / Quinasa de Punto de Control 2 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Africa Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Proteínas Nucleares / Proteína BRCA1 / Proteínas Supresoras de Tumor / Proteína BRCA2 / Neoplasias de la Mama Triple Negativas / Quinasa de Punto de Control 2 Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Middle aged País/Región como asunto: Africa Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2015 Tipo del documento: Article País de afiliación: Sudáfrica Pais de publicación: Reino Unido